The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.
The Infectious Diseases Society of America announced today that it will be relocating its headquarters to 4040 Wilson Boulevard in the Ballston Quarter area of Arlington, Va., a hub of advanced research learning, technology and science in the Washington, D.C. metro area.
Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.
The Infectious Diseases Society of America (IDSA) Foundation, with generous support from Alzheimer’s Germ Quest, Inc. and The Benter Foundation is offering five, one-time $100,000 grants to researchers seeking to identify a potential infectious link to the disease.
The Department of Health and Human Services’ decision to halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health imperils quest for cures of HIV other life-threatening diseases.
The introduction of the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms -- DISARM -- Act -- by United States Senators Johnny Isakson (R-GA) and Bob Casey (D-PA) Tuesday represents an essential step toward addressing the growing threat of infections that are increasingly resistant to existing treatments.
The Ebola outbreak in the Democratic Republic of Congo’s North Kivu province remains uncontrolled despite heroic efforts on the part of international and local responders. The spread of the disease continues to pose imminent risks of cross-border transmission.
Once again rejecting proposed cuts to vital domestic and global health programs and research, House appropriators Wednesday approved funding for fiscal year 2020 that demonstrates commitment to tackling critical health challenges and threats at home and abroad.
The announcement by the Centers for Disease Control and Prevention Wednesday that measles cases in the United States have reached numbers unseen since the disease was declared eliminated here in 2000 brings with it the real possibility that measles could again become endemic in this country.
News today that the antibiotic producer Achaogen has filed for bankruptcy represents the most recent consequence of the steep economic challenges facing antibiotic research and development.
An article published in the Journal of Infectious Diseases calls on the federal government to support coordinated and strengthened responses to the spread of infections associated with the opioid crisis.
The Kentucky governor’s decision this week to voice support for the irresponsible practice of deliberately exposing children to chickenpox as an alternative to vaccination is gravely concerning.